Home Newsfeeds Needham Maintains Buy on Veeva Sys, Raises Price Target to $220

Needham Maintains Buy on Veeva Sys, Raises Price Target to $220

Needham analyst Ryan MacDonald maintains Veeva Sys (NYSE:VEEV) with a Buy and raises the price target from $205 to $220.

byBenzinga Newsdesk

December 2, 2022

1 minute read

Needham analyst Ryan MacDonald maintains Veeva Sys (NYSE:VEEV) with a Buy and raises the price target from $205 to $220.

Dow Starts Commercial Operations Of Its Adhesive And Gap Filler Production Line At Its Polyurethanes Systems House In Ahlen, Germany

By Benzinga Newsdesk

May 16, 7:25 AM

Dow (NYSE:DOW) announced today the mechanical completion of its new VORATRON™ Polyurethanes Systems adhesive and gap filler production line at its Polyurethanes Systems House in Ahlen, Germany. Dow

DOW

Intensity Therapeutics, Inc. IPO Indicating $5.10/Share; IPO Priced At $5/Share On 3.9M Shares

By Happy Mohamed

June 30, 10:53 AM

Intensity Therapeutics, Inc. ("Intensity" or the "Company") (NASDAQ:INTS), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based

INTS

Steve Jobs’ Wife Recalls Apple Co-Founder’s Spiritual Exploration In India And How He Idolized Gandhi

By Navdeep Yadav

September 8, 6:30 AM

Late Apple Inc (NASDAQ: AAPL) co-founder Steve Jobs’ widow Laurene Powell, along with Apple CEO Tim Cook, and former design chief Jony Ive remembered Jobs’ legacy on Wednesday at the Code Conference in Los Angeles, hou

AAPL

Cardio Diagnostics Holdings, Inc Announces Nationwide Launch Of PrecisionCHD For The Fight Against Coronary Heart Disease

By Happy Mohamed

June 21, 8:48 AM

Coronary Heart Disease Detection Test Merges Epigenetic and Genetic Biomarkers with Artificial Intelligence, Offering Remote and Scalable Deployment Capabilities Across the Nation Cardio Diagnostics Holdings, Inc

CDIO

Needham Maintains Buy on Veeva Sys, Raises Price Target to $220

Related Posts

Dow Starts Commercial Operations Of Its Adhesive And Gap Filler Production Line At Its Polyurethanes Systems House In Ahlen, Germany

Intensity Therapeutics, Inc. IPO Indicating $5.10/Share; IPO Priced At $5/Share On 3.9M Shares

Steve Jobs’ Wife Recalls Apple Co-Founder’s Spiritual Exploration In India And How He Idolized Gandhi

Cardio Diagnostics Holdings, Inc Announces Nationwide Launch Of PrecisionCHD For The Fight Against Coronary Heart Disease